ArticleScientific reports2026
An Illumina-based amplicon sequencing approach designed to determine grapevine fanleaf virus isolates.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Traditionally, to comprehensively assess the genetic diversity of a viral isolate, i.e. the population of variants, many molecular steps are necessary, mostly involving PCR amplification, cloning and Sanger sequencing. Lately, with its advent, high throughput sequencing (HTS) has become the method of choice. Both approaches, while extremely informative, may not be economically advantageous to use on a large scale, especially when dealing with highly complex viral populations. Here, we describe an Illumina-based amplicon sequencing (AmpSeq) approach, associated with an analytical workflow for rapid diagnostic, combining HTS quality screening at a more affordable cost. Our multi-primers assay was designed to identify a large diversity of both genomic RNAs (RNA1 and RNA2) of Nepovirus foliumflabelli (also known as Grapevine fanleaf virus, GFLV), compatible with the known genetic diversity of this bipartite virus down to detecting rare variants (i.e. present at less than 2% in an isolate). Beyond diagnostics, our approach can be used and adapted to characterize GFLV populations across vineyards as well as to support the development of GFLV cross-protected vines in France.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.